ProfileGDS4718 / 233970_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 78% 63% 69% 69% 70% 85% 76% 76% 69% 69% 84% 69% 74% 92% 80% 73% 74% 86% 77% 58% 70% 73% 71% 73% 74% 91% 72% 87% 71% 87% 76% 87% 62% 76% 76% 84% 69% 75% 71% 73% 69% 72% 81% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.6243178
GSM549102patient 115, normal, homogenized [OPG study]6.3268463
GSM549104patient 119, normal, homogenized [OPG study]6.8297269
GSM549108patient 138, normal, homogenized [OPG study]6.7768969
GSM549119patient 077, normal, homogenized [OPG study]6.879770
GSM549133patient 032, cancer, homogenized [OPG study]8.5980185
GSM549139patient 042, cancer, homogenized [OPG study]7.4781676
GSM549099patient 107, normal, homogenized [OPG study]7.3589776
GSM549109patient 139, normal, homogenized [OPG study]6.7518169
GSM549110patient 046, normal, homogenized [OPG study]6.7800869
GSM549114patient 063, normal, homogenized [OPG study]8.4634884
GSM549122patient 082, normal, homogenized [OPG study]6.8294469
GSM549134patient 033, cancer, homogenized [OPG study]7.2685774
GSM549136patient 036, cancer, homogenized [OPG study]9.5251792
GSM549140patient 044, cancer, homogenized [OPG study]7.8992480
GSM549111patient 047, normal, homogenized [OPG study]7.1688473
GSM549113patient 057, normal, homogenized [OPG study]7.2823474
GSM549132patient 031, cancer, homogenized [OPG study]8.6425786
GSM549137patient 038, cancer, homogenized [OPG study]7.6128977
GSM549142patient 047, cancer, homogenized [OPG study]6.0768358
GSM549100patient 110, normal, homogenized [OPG study]6.83970
GSM549107patient 135, normal, homogenized [OPG study]7.130973
GSM549115patient 068, normal, homogenized [OPG study]6.9988171
GSM549116patient 072, normal, homogenized [OPG study]7.2115373
GSM549120patient 078, normal, homogenized [OPG study]7.2648274
GSM549131patient 030, cancer, homogenized [OPG study]9.4380291
GSM549118patient 074, normal, homogenized [OPG study]7.10272
GSM549129patient 027, cancer, homogenized [OPG study]8.6586787
GSM549123patient 088, normal, homogenized [OPG study]6.9397871
GSM549124patient 006, cancer, homogenized [OPG study]8.5717387
GSM549126patient 015, cancer, homogenized [OPG study]7.3904376
GSM549128patient 025, cancer, homogenized [OPG study]8.7932187
GSM549103patient 117, normal, homogenized [OPG study]6.2781262
GSM549117patient 073, normal, homogenized [OPG study]7.4118876
GSM549138patient 041, cancer, homogenized [OPG study]7.432276
GSM549141patient 045, cancer, homogenized [OPG study]8.4769284
GSM549130patient 028, cancer, homogenized [OPG study]6.8056469
GSM549101patient 111, normal, homogenized [OPG study]7.2920775
GSM549105patient 128, normal, homogenized [OPG study]6.9767171
GSM549106patient 134, normal, homogenized [OPG study]7.2523673
GSM549112patient 048, normal, homogenized [OPG study]6.7606669
GSM549125patient 011, cancer, homogenized [OPG study]7.0149972
GSM549127patient 024, cancer, homogenized [OPG study]8.0059281
GSM549135patient 035, cancer, homogenized [OPG study]7.5287276